Thinking about 2030

2021-6-1

A Call for Innovation: We Need to Go Off Road to Ensure Medication Adherence Amid COVID-19

2021-6-1

Leading Population Health Efforts: The Power of Vowels.

2021-4-5

What Is Your IQ(VIA)

2021-3-1

Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?

2020-10-1

The Idealism of Youth

2020-9-17

90 days in 2020: Covid-19 exposes health equity opportunities

2020-9-17

Are nursing homes covid-19’s “contaminated wells,” and will they receive additional resources?

2020-9-1

Medication Adherence, Treatment Patterns, and Dose Reduction in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone Acetate or Enzalutamide.

2017-9-1

Value Frameworks in Oncology: Comparative Analysis and Implications to the Pharmaceutical Industry.

2017-7-1

The Medical and Economic Burden of Narcolepsy: Implications for Managed Care.

2017-7-1

Overview of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Patients with Type 2 Diabetes.

2017-6-1

Multispecialty Rating of Evidence-Based Conditions for Intravenous Immunoglobulin Therapy Using a 3-Axis Prioritization Algorithm.

2017-5-16

Assessment of Real-World Central Nervous System Events in Patients with Advanced Prostate Cancer Using Abiraterone Acetate, Bicalutamide, Enzalutamide, or Chemotherapy.

2017-5-1

Academic Detailing Has a Positive Effect on Prescribing and Decreasing Prescription Drug Costs: A Health Plan's Perspective.

2017-5-1

Rate of Adverse Events and Healthcare Costs Associated with the Topical Treatment of Rosacea.

2017-5-1

Does a Free Office Visit Affect Primary Care-Seeking Behavior? A Study of New Exchange Health Plan Enrollees in Mississippi.

2017-4-1

Biologic Disease-Modifying Antirheumatic Drugs in a National, Privately Insured Population: Utilization, Expenditures, and Price Trends.

2017-2-1

Sociodemographic Determinants of Out-of-Pocket Expenditures for Patients Using Prescription Drugs for Rheumatoid Arthritis.

2017-2-1

Use of the Prostate Core Mitomic Test in Repeated Biopsy Decision-Making: Real-World Assessment of Clinical Utility in a Multicenter Patient Population.

2016-12-1

Treatment Patterns and Outcomes in Patients with Varicose Veins.

2016-11-16

Effects of Specialty Pharmacy Care on Health Outcomes in Multiple Sclerosis.

2016-11-1

Clinical Characteristics and Unmet Need Among Patients with Atherosclerotic Cardiovascular Disease Stratified by Statin Use.

2016-11-1

Examining the Value of Subsidies of Health Plans and Cost-Sharing for Prescription Drugs in the Health Insurance Marketplace.

2016-10-1

Thromboembolic Events Associated with Bevacizumab plus Chemotherapy for Patients with Colorectal Cancer: A Meta-Analysis of Randomized Controlled Trials.

2016-6-1

Economic Burden of Toxicities Associated with Treating Metastatic Melanoma in the United States.

2016-6-1

The Prevalence and Determinants of Controlled Substance Discrepancies in a Level I Trauma Hospital

2016-5-1

Inpatient Utilization and Costs for Medicare Fee-for-Service Beneficiaries with Heart Failure.

2016-4-1

The Year 2015 Had Highest Number of Drug Approvals in the New Millennium, but with Controversy

2016-3-24

Key Features of Academic Detailing: Development of an Expert Consensus Using the Delphi Method.

2016-2-1

Optimizing Rheumatoid Arthritis Therapy: Using Objective Measures of Disease Activity to Guide Treatment.

2015-10-1

The Continuing Clinical and Economic Burden of Cardiometabolic Health.

2015-9-28

Resource Utilization for Chemotherapy-Induced Nausea and Vomiting Events in Patients with Solid Tumors Treated with Antiemetic Regimens.

2015-9-18

Health Economics in Oncology: A Necessary Tool for Value-Based Patient Care.

2015-6-22

Demonstrating Value for Biosimilars: A Conceptual Framework.

2015-6-3

Diabetes Management: An Accountable Care Perspective.

2015-4-1

The cost of unintended pregnancies for employer-sponsored health insurance plans.

2015-4-1

Viekira Pak (Ombitasvir, Paritaprevir, and Ritonavir Tablets; Dasabuvir Tablets): All-Oral Fixed Combination Approved for Genotype 1 Chronic Hepatitis C Infection.

2015-3-1

Budgetary Impact of Adding Riociguat to a US Health Plan for the Treatment of Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension.

2014-12-1

Diagnosis and treatment of bipolar disorders in adults: a review of the evidence on pharmacologic treatments.

2014-12-1

Cardiometabolic Health in 2014: Clinical and Economic Implications.

2014-11-21

Evaluation of dabigatran for appropriateness of use and bleeding events in a community hospital setting.

2014-11-3

New and emerging drugs and targets for type 2 diabetes: reviewing the evidence.

2014-11-1

Patient preferences and treatment adherence among women diagnosed with metastatic breast cancer.

2014-10-1

Cancer Care in 2014: Continuing Challenges, New Opportunities

2014-5-1

Stakeholder Perspective: Cardiovascular Safety of Azithromycin Therapy: Revisiting the Evidence

2014-1-1

Stakeholder Perspective: The Clinical Toll of Nonvalvular Atrial Fibrillation Poses Significant Economic Burden

2014-1-1

Fall Follies: The ACA Lurches into Operation.

2013-9-1

Cardiometabolic Risk Factors: Novel Approaches Can Improve Patient Outcomes.

2013-9-1

Progress in Cancer Care: Challenges and Opportunities.

2013-7-18